Total planned funding: $207,741,900
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $135,006,067 |
Uganda | $20,682,980 |
Côte d'Ivoire | $8,561,000 |
Rwanda | $5,850,000 |
Guyana | $5,338,112 |
Ethiopia | $5,236,344 |
Zambia | $5,080,000 |
Nigeria | $3,641,550 |
Botswana | $3,355,175 |
Vietnam | $3,244,565 |
Kenya | $2,197,780 |
Namibia | $1,892,925 |
Cameroon | $1,349,000 |
Haiti | $1,261,727 |
Mozambique | $1,045,000 |
Tanzania | $1,000,000 |
Zimbabwe | $840,000 |
Russia | $650,000 |
South Sudan | $330,000 |
Ghana | $300,000 |
Ukraine | $300,000 |
Dominican Republic | $229,675 |
Cambodia | $200,000 |
Angola | $150,000 |
India | $0 |
Eswatini | $0 |
China | $0 |
Malawi | $0 |
Lesotho | $0 |
Indonesia | $0 |
Thailand | $0 |
Democratic Republic of the Congo | $0 |
Organizational Types
Implementing Agency | $207,741,900 |
Program Areas
Treatment | $74,569,195 |
Care | $46,642,685 |
Prevention | $45,650,335 |
Governance and Systems | $28,922,425 |
Testing | $11,857,260 |
Management and Operations | $0 |
Budget Codes
HTXS: Treatment: Adult Treatment | $59,194,960 |
HVTB: Care: TB/HIV | $16,843,148 |
HKID: Care: Orphans and Vulnerable Children | $15,811,887 |
HBHC: Care: Adult Care and Support | $12,403,140 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,903,076 |
HVCT: Testing: HIV Testing and Counseling | $11,857,260 |
HVSI: Strategic Information | $11,807,238 |
OHSS: Health Systems Strengthening | $11,400,935 |
HVOP: Sexual Prevention: Other Sexual Prevention | $10,326,160 |
HMBL: Biomedical Prevention: Blood Safety | $9,426,500 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,423,492 |
PDTX: Treatment: Pediatric Treatment | $8,451,240 |
HTXD: Treatment: ARV Drugs | $6,922,995 |
HLAB: Laboratory Infrastructure | $5,714,252 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,296,107 |
PDCS: Care: Pediatric Care and Support | $1,584,510 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $200,000 |
HMIN: Biomedical Prevention: Injection Safety | $75,000 |
HVMS: Management and Operations | $0 |
Top Partner Programs
University of the Witwatersrand:
$79,450,698
View countries
TB/HIV Care Association:
$14,093,785
View countries
U.S. Centers for Disease Control and Prevention:
$9,744,568
View countries
All Countries
2012 | $9,744,568 |